Hotbed/Location
Filter News
Found 736,779 articles
-
AMAG Pharmaceuticals, Inc. Announces Preliminary Results from its Phase III Study Evaluating Feraheme Compared to IV Iron Sucrose in Patients with Iron Deficiency Anemia
3/8/2012
-
BioMarin Pharmaceutical Inc. Completes Enrollment for Phase 3 Trial for GALNS for the Treatment of MPS IVA
3/8/2012
-
Novartis Pharmaceuticals Corporation Release; Data in NEJM Shows Novartis Drug Signifor® is First Therapy to Provide Rapid, Durable Benefit for Cushing's Disease Patients in Phase III Study
3/8/2012
-
Palatin Technologies Completes Enrollment in Phase 2B Bremelanotide Female Sexual Dysfunction Trial
3/8/2012
-
Cytheris SA Announces Results of Phase II Study Indicating That Recombinant Interleukin-7 (CYT107) Expands CD4 T-Cells in Gut Mucosa of Chronically HIV Infected Immunological Non-Responder Patients
3/8/2012
-
Michael E. DeBakey VA Medical Center Initiates Phase 2A Trial in Cancer Cachexia with AEterna Zentaris' Ghrelin Agonist, AEZS-130
3/8/2012
-
Ultragenyx Announces the Completion of the Phase 1 Clinical Study of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
3/8/2012
-
Sosei Group Corporation Announces Initiation of Phase I Study for SO-1105
3/8/2012
-
Cannabis Science Inc. Reports Cancer Tumors Continues to Shrink and Die as Apparent Pieces of the Dying Cancer Tumors Begin to Fall off as Evidenced in Newest Photos of the 3rd Squamous Cell Carcinoma Patient
3/8/2012
-
Promedior Receives U.S. Orphan Drug Designation for PRM-151 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
3/8/2012
-
Study Establishes XOMA (US) LLC's XMetA as the First Allosteric Insulin Receptor-Activating Antibody to Improve Glycemic Control In Vivo
3/8/2012
-
Kibow Biotech, Inc. Release: Interim Clinical Trial Results Confirm Safety of Renadyl(TM), a Probiotic Dietary Supplement for the Support of Healthy Kidney Function
3/8/2012
-
Hi-Tech Pharmacal Acquires a Line of Branded Homeopathic Nasal Spray Products
3/8/2012
-
Celgene Corporation Completes Acquisition of Avila Therapeutics
3/8/2012
-
Lipid Therapeutics Licenses European Rights to its Lead Product, LT-02, to Co-development Partner Dr. Falk Pharma GmbH
3/8/2012
-
Prime Therapeutics Announces CareCentered Contract(TM) with EMD Serono, Inc. (Rockland) for MS Drug Rebif(R)
3/8/2012
-
Alexza Pharmaceuticals, Inc. and Grupo Ferrer Internacional S.A. Amend Adasuve(TM) Partnership
3/8/2012
-
REGENX Biosciences, LLC and Asklepios BioPharmaceutical, Inc. Enter Into Agreement for the Development of Treatments for Hemophilia A Using NAV(TM) rAAV8 Vectors
3/8/2012
-
Boston Scientific Corporation Renews Agreement with Lumenis, Inc. to Deliver Innovative Laser Products to Treat Urologic Conditions
3/8/2012
-
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) Signs Exclusive Worldwide License With Yale University for Treatment of Type 1 Diabetes Using Stem Cells
3/8/2012